Effectiveness and Safety of Two Thrombopoietin Receptor Agonists: A Retrospective Cohort Study of Adults With Primary Immune Thrombocytopenia
Cureus · 21.07.2026
DOI: 10.7759/cureus.113083 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Cureus, erschienen am 21.07.2026. Verfasst von Diego G Lanza und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Universidad Nacional de Colombia, Bogota, COL. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Universidad Nacional de Colombia, Bogota, COL.
- Department of Medicine, Hospital Universitario Nacional de Colombia, Bogota, COL.
- Department of Hematology, Hospital Universitario Nacional de Colombia, Bogota, COL.
Zitieren
APA
Lanza, D. G., Enciso, L. J., Moncaleano, L. G., & Rodríguez, M. A. (2026). Effectiveness and Safety of Two Thrombopoietin Receptor Agonists: A Retrospective Cohort Study of Adults With Primary Immune Thrombocytopenia. Cureus. https://doi.org/10.7759/cureus.113083
Vancouver
Lanza DG, Enciso LJ, Moncaleano LG, Rodríguez MA. Effectiveness and Safety of Two Thrombopoietin Receptor Agonists: A Retrospective Cohort Study of Adults With Primary Immune Thrombocytopenia. Cureus. 2026. doi:10.7759/cureus.113083
BibTeX
@article{Lanza2026,
author = {Lanza, Diego G and Enciso, Leonardo J and Moncaleano, Luis G and Rodríguez, María A},
title = {Effectiveness and Safety of Two Thrombopoietin Receptor Agonists: A Retrospective Cohort Study of Adults With Primary Immune Thrombocytopenia},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.113083}
}
EUVIMED